AUROPHARMA taking support on monthly trend line and 20 dma

업데이트됨
its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.
노트
usa decision to reduce drug prices may have negative impact.
little bad news for pharma companies.
Chart PatternsTechnical IndicatorsTrend Analysis

또한 다음에서도:

면책사항